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Abstract 
Psychotropic medications should be used with extreme caution in older adults residing in long-
term care facilities. Delirium and altered mental status are associated with multiple complex 
underlying medical conditions and can be difficult to recognize, particularly among the elderly 
residing in long-term care facilities. The use of the California Department of Public Health 
(CDPH) Skilled Nursing Facility (SNF) Antipsychotic Toolkit allows for ethical and evidence-
based care of the elderly within the regulations and best practice for use of antipsychotics. This 
Doctor of Nursing Practice quality improvement project is designed to provide a toolkit for 
practitioners of behavioral modification measures and an introduction to the CDPH SNF 
Antipsychotic Toolkit for use among local nursing homes in the San Francisco Bay Area of 
California. The clinical relevance is for geriatric nurses and health care providers to recognize 
value of utilizing the CDPH SNF Antipsychotic Toolkit before prescribing and administering 
antipsychotic medications to the older adult population in nursing homes. The toolkit emphasizes 
the importance of recognizing possible adverse effects and the importance of identifying 
delirium and interventions. 
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Section II: Introduction 
Problem Description 
According to the National Center for Health Statistics, 47.8% of patients residing in long-
term care (LTC) facilities have been diagnosed with Alzheimer’s disease or other dementia 
(Centers for Disease Control and Prevention [CDC], 2016). Individuals with dementia are at 
great risk of developing delirium secondary to age-related changes. As a result, the pain process 
is altered, they are less able to ask for help with basic needs, and they are less able to 
communicate that they are in pain or feeling unwell (Featherstone, Hopton, & Siddigi, 2010). It 
is important that health care workers, nursing, and support staff understand how to prevent, 
recognize, and manage delirium, because delirium can be mistaken as dementia.    
Delirium and altered mental status are associated with multiple complex underlying 
medical conditions that can be difficult to recognize, particularly among elderly residing in LTC 
facilities. The American Psychiatric Association’s Diagnostic and Statistical Manual, 5th edition 
(DSM-V) lists five key features that manifest delirium: (a) disturbance in attention and 
awareness; (b) the disturbance develops over a short period of time, represents a change from 
baseline; (c) disturbance in cognition (memory deficit, disorientation, or perception); (d) the 
disturbances are not better explained by preexisting disorder or established as neurocognitive 
disorder; and (e) there is evidence from the history, physical examination, or laboratory findings  
that the disturbance is caused by a medical condition, substance intoxication or withdrawal, or 
medication side effect (in Francis & Young, 2014). Although a number of criteria exist for 
dementia, the DSM-V criteria for dementia include the following: (a) significant cognitive 
impairment in at least one of the cognitive domains (learning and memory, language, executive 
function, complex attention, perceptual-motor function, and social cognition); (b) impairment 
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represents a significant decline from previous level of functioning; and (c) cognitive deficits 
interfere with independence in everyday activities (Larson, 2016).   
Failure to assume responsibility of nursing home management, licensed nurses, and most 
especially, nurse practitioners and medical doctors who are prescribing the antipsychotic 
medications, can lead to very serious consequences and even death in elderly patients. Progress 
has been shown with the Centers for Medicare and Medicaid Services’ (CMS) strategies to 
reduce antipsychotic drug use in nursing home residents with dementia. Continuous monitoring 
and consistent enforcement are needed to ensure decline in unnecessary use of antipsychotics 
and psychoactive medications in nursing homes (Lucas & Bowblish, 2017).  
Ferguson, Montgomery, Mossey and Duncan (2018), in a summarized evidence of non-
pharmacological nursing interventions for delirium prevention in LTC facilities, concluded that 
there is limited evidence on nursing interventions to prevent delirium in LTC facilities. Ferguson 
et al. reported (a) an increased need for education of delirium risk factors, (b) the importance of 
knowledge of the resident as an individual, and (c) potentially modifiable risk factors associated 
with increased delirium severity, such as dehydration, disorientation, absence of assisted device, 
absence of family member, environmental management, constipation prevention, physician/staff 
communication, catheter care, pain management, and use of physical restraints. The 
physiological symptoms and behavior of delirium may include challenging behaviors, such as 
altered mental status, agitation, restlessness, yelling, crying, and refusal of care (Mayo Clinic, 
2018). Though these behaviors are common, they may be socially unacceptable in nursing 
homes. These behaviors can interfere with residents’ activities of daily living, such bathing, 
feeding, walking, toileting, and bed transfer.  
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Daly, Bay, Levy, and Carnahan (2015) reported, “More than 80% of nursing home 
residents with dementia exhibit one or more challenging behaviors … (including) agitation, 
anger, depression, disrobing, eating abnormalities, hoarding, inappropriate sexual behavior, 
irritability, paranoia, physical and verbal aggression, repetition, swearing, and withdrawal” (p. 
182). Nurses can use behavioral modification techniques to ameliorate these behaviors; however, 
these interventions can be time consuming (Weinberg, 2016). Staff may seek pharmacologic 
methods to manage behaviors, but using antipsychotic medications inappropriately as a chemical 
restraint is unethical and may cause adverse effects for elderly individuals (Department of Health 
& Human Services [DHSS], 2014).  
Current Nursing Home Practice 
Nursing homes are often short staffed, and the staff work long hours with a high volume 
of residents. Certified nursing assistants (CNAs) provide much of the care in nursing homes. 
Routine CNA duties in nursing homes include providing activities of daily living, such as 
feeding, bathing, toileting, transferring, and walking or exercising the residents (California 
Department of Human Resources, 2017). When staffing is short, CNAs are assigned additional 
residents, which increases their normal workload (Weinberg, 2016). These factors contribute to 
the lack of time needed to implement behavioral management of residents with disruptive 
behaviors. For these reasons, staff often pressure prescribers to order psychotropic medications 
to control nursing home resident behaviors rather than using behavior modification to manage 
these challenging behaviors (Tjia, Gurwitz, & Briesacher, 2012). Unfortunately, many residents 
are given antipsychotic medications as an initial intervention to manage their challenging 
behaviors without a proper interdisciplinary evaluation. Because of lack of training in behavioral 
management and lack of knowledge in the use of psychotropic drug therapy, nursing staff may 
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not be aware of the dangers of these medications in the older adult population and may not be 
prepared to adequately care for residents with challenging behaviors (Daly et al., 2015). Staff 
may seek pharmacological methods using psychotropic drugs to manage behaviors.  
Available Knowledge 
Despite the black box warning issued by the Food and Drug Administration (FDA), 
nursing home residents continue to receive antipsychotic medication as initial intervention for 
behavioral modification. Levin (2012) noted, the “FDA issued the black box warnings for 
antipsychotics in response to approximately 15,000 elderly nursing home residents dying each 
year from the off-label use of antipsychotic drugs” (p. 12). Prescribing these medications when 
they are not medically indicated or in the patient’s best interest is the same as using a chemical 
restraint and/or unnecessary drug. 
In a literature review, Pakpoor and Agius (2014) found that neuroleptic malignant 
syndrome, which includes fever, diaphoresis, rigidity, confusion, fluctuating consciousness, 
fluctuating blood pressure, tachycardia, leukocytosis, and altered liver function tests, was a fatal 
side effect for all antipsychotic medications. These side effects can lead to fatality, most 
especially in an older adult because of age-related changes that affect kidney, liver, and 
gastrointestinal function. The aging process can affect how the body metabolizes a drug from 
ingestion to secretion through the kidneys, as well as specific action of the medications in fragile 
older individuals (Braun & Frolik, 2000). Free radicals that are by-products of metabolism cause 
oxidative damage to biomolecules as they damage the cellular membranes and impair 
physiological functioning (Miller, 2018). Antipsychotic medication when used in the older adult 
population needs frequent monitoring of side effects, vital signs, lab work, and possible dose 
regulation due to the differences in body chemistry and drug metabolism in this population. 
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A cohort study conducted by Huybrechts et al. (2012) included 83,959 Medicaid 
recipients, age 65 or older, in 45 nursing homes in the United States, who initiated atypical 
antipsychotic medication treatment after nursing home admission from 2001 to 2005.  
Huybrechts et al. concluded that bacterial infections, myocardial infarctions, and hip fracture 
rates were higher, and there was a risk of cerebrovascular events in those who initiated with 
antipsychotic medications in nursing homes. Demonstrative conclusions were reached regarding 
the adverse impact of antipsychotic medication, which can be fatal in the older adult population 
(Huybrechts et al., 2012).   
Alzheimer’s disease is a cognitive disorder that can manifest behavioral symptoms of 
agitation or aggression (Lyketsos et al., 2011). These types of behaviors can be overwhelming to 
residents, as well as to caregivers. According to the Alzheimer’s Association (2007), more than 
50% of nursing home residents have some form of dementia or cognitive impairment, and many 
residents with cognitive impairment manifest challenging behaviors, such as kicking, 
restlessness, agitation, yelling, or refusing to receive care. Frequently, antipsychotic medications 
are used as initial interventions, which may be why the use of antipsychotics has increased. It is 
clear that many of these symptoms are physiological, are to be expected, and should not be 
treated with antipsychotic medications.  
Bonner et al. (2015) conducted a qualitative study of residents diagnosed with dementia 
who received an antipsychotic medication. Bonner et al. conducted the research at 26 medium 
and large facilities in five CMS regions. The researchers concluded that many of the prescribed 
psychotropic drugs lacked evidence of supporting documentation for medication necessity or 
proper diagnosis in the resident’s medical record (Bonner et al., 2015). 
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It is critical for clinicians to recognize and uncover the underlying medical conditions of 
behavioral disturbance or altered mental status for elderly residing in LTC facilities. Kiely et al.  
(2013) studied delirium in 2,158 patients newly admitted to a post-acute facility and, using the 
diagnostic algorithm of the Confusion Assessment Method, found approximately 16% of these 
patients had delirium. In a 2009 study, High et al. concluded noted urinary tract infection at an 
incidence of 0.12% cases per 1,000 resident-days. High et al. also found that pneumonia 
develops among elderly nursing home residents at a rate of one episode per 1,000 days of care. 
The elderly residing in LTC facilities are at greater risk for infection because of multiple 
comorbidities that complicate in identifying such infections.   
Basso, Siminioato, Dimonte, Scaglione, and Campagna (2018) conducted a retrospective 
descriptive study using nursing home clinical records data from 2013 to 2016. Basso et al. found 
that during that time period, 143 emergency department accesses occurred, with 55 (38.6%) for 
medical problems in 48 residents. The most frequent reason for hospitalization was infection 
(22): 18 respiratory infections, two urinary infections, and two with both respiratory and urinary 
infection. On emergency department admission, prevalent signs and symptoms were desaturation 
(13), dyspnea (10), and fever (nine). Basso et al. stressed the importance of explicit criteria to 
promptly monitor changes in clinical conditions and the importance of educating professionals to 
suspect an infection even with non-specific symptoms.   
Ferguson et al. (2018) conducted a systemic review of 23 international studies to examine 
the status of older adults living in LTC facilities and found variation in fluid intake intervention 
and associated measurement of hydration outcomes. Across all of the reviewed evidence, 
dehydration was identified as a leading threat to the health status of residents in LTC facilities 
(Ferguson et al., 2018).  
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Rationale 
Dr. Jean Watson’s nursing theory of philosophy and science of caring promotes the health 
of the nurse and the wellbeing of the patient (McEwen & Wills, 2014). Dr. Watson believes that 
nurses are caring.  She defines the nursing care profession as it combines with human and 
scientific values to provide patient care. The theory assumption is that health professionals make 
social, moral, and scientific contributions to humankind and that nurses’ caring ideal can affect 
human development (McEwen & Wills, 2014). Dr. Watson believes that nursing care is a 
transforming process for both the patient and the nurse. Philosophy and science of caring defines 
the interpersonal process in the fulfillment of a patient’s need as the result of caring (McEwen & 
Wills, 2014). For example, the facility or providers should find behavior modification 
alternatives or examine the cause of the behaviors before prescribing antipsychotic medication. 
Non-pharmacological interventions include redirection, encouraging residents to verbalize 
feelings, music, art, massage, or providing other activities that residents enjoy.   
Dr. Watson defined three of the four metaparadigm concepts (human being, health, and 
nursing), and these concepts support the California Department of Public Health (CDPH) Skilled 
Nursing Facility (SNF) Antipsychotic Toolkit (see Appendix A; McEwen & Wills, 2014). The 
toolkit upholds the philosophy and science of caring. Examples of use of the toolkit include, 
health care providers should examine the pathological causes of behavioral disturbance, and 
residents presenting with behavioral and psychological symptoms of dementia should undergo 
routine blood analysis and urinalysis. This can lead to both recognition of delirium and reduced 
usage of antipsychotic medication (Wilson, Power, Owens, & Lawlor, 2019).   
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Project Purpose 
Specific Aims 
Introduction of the CDPH SNF Antipsychotic Toolkit may reduce the rate of prescribing 
antipsychotic medications compared to usual practice of antipsychotic use. Delirium and altered 
mental status are associated with multiple complex underlying medical conditions and can be 
difficult to recognize, particularly among elderly residing in LTC facilities. This DNP quality 
improvement project involved the introduction of the use of the CDPH SNF Antipsychotic 
Toolkit in the context of an educational training workshop designed to minimize negative effects 
of age-related changes and modifiable risk factors of delirium. Three SNFs in Northern 
California were invited to participate in the educational workshop training.  
Goals 
The quality improvement goals of this DNP project are:   
1. Provide a mini course in behavioral modification interventions appropriate for the 
older adult. 
2. Introduce the CDPH SNF Antipsychotic Toolkit. 
3. Encourage participating SNF staff to utilize the CDPH SNF Antipsychotic Toolkit. 
4. Introduce the CDPH SNF Antipsychotic Toolkit into the facility policy for care.  
Objectives 
The objectives of this DNP project include:   
1. Identify at least five SNFs in Northern California willing to coordinate educational 
workshop training in reducing antipsychotics use, including criteria for delirium and 
dementia by December 2018. 
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2. Design a lesson plan and learning objectives workshop educational training 
presentation by March 2019. 
3. Design a tool to analyze effectiveness of educational workshop training (e.g., pre- and 
post-survey workshop evaluation).   
4. Present findings to interdisciplinary team (nursing home administrator [NHA], 
director of nursing [DON] services, social worker, nursing staff, and rehabilitation 
therapist) by July 2019. 
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Section III. Methods 
Context 
The key members and stakeholders on this DNP project included the NHA, the DON, 
social worker, nursing staff, health care provider, and rehabilitation therapist. Licensed nurses 
should receive continuing education in taking care of the geriatric population, especially the side 
effects of psychotropic medications and the guidelines in administration of psychotropic 
medications. Educational training included identifying and preventing delirium, which can have 
a positive effect on quality of care in nursing homes. The educational lecture included the 
biologic theories of aging. Strengths, weaknesses, opportunities, and threat analysis (SWOT, see 
Appendix B) and gap analysis (see Appendix C) of DNP project were identified. 
Local Problem 
A random review of public records in the Health Facilities Consumer Information System 
under the CDPH noted a nursing home was cited for a FTAG 154 Informed of Health, Care, & 
Treatments in March 2017 during the annual CDPH audit (see Appendix D). Based on the survey 
audit, interviews, and record reviews, the facility failed to follow its policy and procedure to 
ensure a physician-obtained informed consent for psychotherapeutic medication in a timely 
manner prior to administering. This failure had a potential for a random sample resident 
receiving psychotherapeutic medications without information needed to weigh benefits against 
risk associated with psychotherapeutic medications, putting at risk for medication-associated 
injury and harm (CDPH, 2017, p. 2). Using the CDPH SNF Antipsychotic Tool, along with 
behavior modification techniques, is an ethical process that provides guidance in the appropriate 
use of antipsychotics in older adults in nursing homes.   
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The first step was contacting the NHA and the DON to collaborate for educational 
workshop training through emails and phone calls. The NHA and the DON help to approve and 
set up the workshop training in their facilities. Seven SNFs in Northern California were 
contacted and three SNFs (Oakland, Hayward, and San Jose) agreed to the training. The training 
was completed in December 2018.  
In the second step, the DNP student integrated a literature review related to use of 
antipsychotic medications in nursing homes. A comprehensive literature review to support these 
recommendations was completed through Scopus, CINAHL, Joanna Briggs Institute EBP 
Database, PubMed databases, and UpToDate. Search terms used were antipsychotic, adverse 
effects, nursing home, dementia, Alzheimer, prevalence, assisted living facility, psychotropic, side 
effects, chemical restraints, geriatric, and morale nursing home staffing. Publication dates for the 
literature search were limited to 2000 to 2019. Limited information was found with initial date 
limitation of five years, so the literature search was expanded to 20 years, then to less than 10 
years, resulting in 166 articles. The critical appraisal of evidence (see Appendix E) noted 
research from 2012 to 2018 relevant to the DNP project. The search was refined by limiting 
acceptance of articles published in less than 10 years, English, reviews of the literature, 
qualitative and quantitative research involving the geriatric population, LTC facilities, delirium, 
and dementia. Eleven articles were selected applicable to the DNP project based on clinical 
practice guidelines. These articles and systemic review significantly emphasized the effect of 
antipsychotics medication in older adults, highlighted inappropriate use of psychoactive 
medications in nursing homes, and emphasized the importance of identifying delirium. This 
process of the DNP program was conducted from Fall 2016 to Spring 2019.   
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In the third step, the DNP student created learning objectives for an educational training 
workshop. The DNP student sought advice from two professors on the student’s committee at the 
University of San Francisco. These two professors are family nurse practitioners with degrees of 
Doctorate of Nursing Practice and Doctor of Philosophy in Nursing. It was identified that criteria 
for dementia and delirium should be included in the workshop educational training.   
Timeline 
The Gantt chart presents the timeframe of DNP project (see Appendix F). The DNP 
student interviewed SNF administrators in December 2018. In January 2019, the SNFs in Bay 
Area, California were contacted to participate in the educational training program in managing 
use of antipsychotics and in recognizing symptoms of delirium. The lesson plan for in-service 
training was developed in February 2019. Itemized materials and tools for workshop training 
were finalized in March 2019. Workshop training was completed June 3, 2019. Synthesis of data, 
summarized recommendations, and outcome findings were concluded June 5, 2019.   
Cost Summary and Benefits Analysis 
LTC facilities are required to provide in-service training in managing dementia residents, 
managing residents with behavioral disturbance, and the use of psychotropic medications. There 
was no additional cost to the facilities for this DNP project, as this project can be used for the 
mandatory in-service trainings.   
 Projected staffing and labor costs are presented as an estimated budget. Rates of 
employees are presented as fair market value in Bay Area, California. In a 50-bed licensed 
skilled nursing home, projected total staffing of three shifts includes 22 CNAs, 12 licensed 
vocational nurses, six registered nurses (RNs), and one social worker. The projected annual cost 
for a 1.5 hour training class is $1,591.50 (see Appendix G).  
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 Inappropriate use of antipsychotic medications in nursing homes can result in substantial 
care deficiency or a resurvey during annual audit from the Department of Health. A declaration 
from State Operations Manual, Survey and Enforcement Process for Skilled Nursing Facilities, 
notes penalties can range from $1,000 to $10,000 per instance (CMS, 2018). Utilizing the CDPH 
SNF Antipsychotic Toolkit is cost effective in avoiding citations and penalties. The check off list 
of the toolkit is a guidance for ethical and evidence-based practice use of antipsychotics in 
nursing homes.   
Return on Investment  
The return on investment in utilizing the CDPH SNF Antipsychotic Toolkit is improving 
the quality of care of nursing home residents. The toolkit will help nursing home staff effectively 
manage the clinical risk factors attributable to antipsychotic medication use in the elderly. 
Nursing home staff will have the knowledge and resources to follow the guidelines step-by-step 
in the use of antipsychotics medication in SNFs. The residents in LTC facilities will benefit from 
using the off-label use of antipsychotics, which will improve the appropriate use of 
antipsychotics in nursing home residents diagnosed with dementia, Alzheimer’s, and/or 
cognitively impaired.    
 The return on investment of utilizing the CDPH SNF Antipsychotic Toolkit is avoidance 
of imposition of civil money penalties from the CMS. A declaration from the State Operations 
Manual, Survey and Enforcement Process for SNF, State Medicaid Agency may impose a civil 
money penalty between $3,050 and $10,000 per day of immediate jeopardy (CMS, p. 7301.1, 
2018).   
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Intervention 
Antipsychotic Use Survey Toolkit 
The use of the CDPH SNF Antipsychotic Toolkit may reduce the use of antipsychotic 
medications compared to the usual practice of prescribing antipsychotic medication (California 
Association of Long-Term Care Medicine, 2012). The CDPH has created a process to monitor 
inappropriate use of psychotropic medication in nursing homes. The CDPH SNF Antipsychotic 
Toolkit checklists for administering antipsychotic medications includes:   
1. Check to be sure behavioral symptoms are not due to:   
a. An underlying medical condition (e.g., delirium, infection, pain, fluid or 
electrolytes imbalance, polypharmacy side effects) that can be resolved or 
improved.  
b. Failure to recognize delirium. Clinicians often fail to recognize delirium, in some 
reports, in more than 70% of cases (Francis & Young, 2014).   
c. Environmental stress and psychological stressors (e.g., abuse, inadequate or 
inappropriate staff response, unfamiliar care provider, change in daily routine). 
d. Psychosis (e.g., auditory, visual, or other hallucinations; delusions) or the 
behavioral symptoms present a danger to the resident or others. 
2. Eliminate those non-evidence-based reasons: 
a. Pertinent non-pharmacological interventions must be attempted, unless 
contraindicated.   
b. The prescribed medication represents the primary indication for use of the 
antipsychotics. 
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c. Monitor for effectiveness of prescribed antipsychotic, as well as the presence of 
adverse consequences. 
d. If the antipsychotic was initiated within the last year, the facility must attempt a 
gradual dose reduction in two separate quarters. 
e. Documentation present in the resident’s clinical record was reviewed monthly by 
a consultant pharmacist. 
f. Determine the prescribing physician provided material information necessary to 
obtain informed consent and received consent from the resident.  
Alternatives to Antipsychotics 
Behavior modification as an alternative to the use of medications may include any of the 
following (California Association of Long Term Care Medicine, 2012):  
• Review medications regimen. Older adults are at a higher risk of adverse drug events 
due to physiological changes with advanced aged. Each medication should be 
evaluated to identify side effects that can possibly cause alterations in mental status 
that can manifest through behavioral disturbance (e.g., restlessness, irritability, 
psychomotor agitation, and confusion). 
• Assess for pathological causes. Assess for underlying medical cause of altered mental 
status. Order laboratory tests, such as comprehensive panel to examine for electrolyte 
imbalance, dehydration, and infection. 
• Assess for depression. Depression can manifest through agitation and irritability; 
physical and verbal aggression may be the primary manifestation of depression. 
• Review pain management. Pain is another example of physiological causes of 
undesired behavior. Many nursing home residents cannot speak out for themselves 
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when they experience pain, which can manifest through change of mood, such as 
agitation, irritability, and restlessness.  
Additional behavior modification recommendations from the Alzheimer’s Association 
(2009) include:   
• Facilitate therapeutic communication. For example, use appropriate communication 
aids or interpreter to meet resident’s communication needs. Use a comforting tone of 
voice.  
• Assess and know the resident well.   Learn to read his or her body language and get to 
know the resident’s preference with care. Provide choices to resident to promote 
dignity and independency.   
• Provide a routine and therapeutic environment.  Allow sufficient time for the resident 
to complete self-care.   
• Build a good rapport with the resident.  Demonstrate a caring attitude, active 
listening, and acknowledgement of resident’s feelings.  
• Avoid interrupting resident with cognitive impairment.  They may lose their train of 
thought. Speak slowly and calmly, and use short, simple words.    
The projected implementation of the project was June 2019 (see Appendix F). The 
development of the manuscript, prospectus development, and DNP project was completed in 
August 2019. The project included educational workshop training, with in-services funded from 
the educational training budget. The training was planned for approximately 45 minutes of 
lecture and 15 minutes for open discussion. Nursing home facilities are mandated to provide 
training in-services for all staff annually on care of dementia residents and managing behavioral 
disturbance. The DNP project did not affect the training budget of the facility.   
HAZARDS OF ANTIPSYCHOTICS IN NURSING HOMES  23 
 
The plan was to communicate to the NHA. The DON and the director of social services 
work strictly on psychotropic medications. The DON coordinates the education for licensed 
nurses and the interdisciplinary team members. A flyer was posted prior to the educational 
training on site (see Appendix H). The work breakdown structure was used in communicating 
with key personnel in the nursing skilled facilities (see Appendix I). Flyers provided to nursing 
skilled facilities that participated in educational training.    
Study of Intervention 
The Department of Public Health (DPH) has created a process to monitor inappropriate 
use of psychoactive medications to determine if clinical notes and care planning support the 
prescription of these drugs. The CDPH SNF Antipsychotic Toolkit is an evidenced-based 
assessment toolkit that allows for ethical care of the elderly within the regulations and 
evidenced-based practice for use of antipsychotics. It is best practice to use the CDPH SNF 
Antipsychotic Toolkit before prescribing and administering antipsychotic medications. The 
toolkit emphasizes the importance of identifying signs and symptoms of delirium with care for 
elderly in nursing homes. It is more ethical if nursing home facilities find behavior modification 
alternatives or examine physiological changes that can alter mental cognition (urinary tract 
infection, dehydration, and pulmonary tract infection) before prescribing and administering 
antipsychotic medication (Alzheimer Association, 2009). The goal of behavioral management is 
to provide health care providers with an understanding of factors that can contribute to cognitive 
impairment in the older adult population, to identify and treat factors that are reversible, and to 
suggest appropriate interventions to promote behavior management (Institute for Caregiver 
Education, n.d). The purpose of this alternative to psychotropic medication is for each resident to 
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attain and maintain his/her highest practicable wellbeing in an environment that prohibits the use 
of restraints for discipline or convenience (DHSS, 2014).  
Measures 
Upon completion of the educational training of the DNP project, the health care provider 
will be able to: 
1. Identify at least three behavioral clinical presentations of delirium in elderly. 
2. Identify behavioral side effects of common medications that could be misdiagnosed 
as dementia or delirium. 
3. Identify at least three possible outcomes from using antipsychotic medications in 
elderly. 
4. Identify possible non-pharmacological interventions in managing delirium or 
dementia with behavioral disturbance. 
5. Identify at least five criteria for psychotropic medication use in a nursing skilled 
facility based on the CDPH SNF Antipsychotic Toolkit. 
Analysis 
The intended outcome of the project was to educate the nursing home staff, including 
providers and nursing home management, that the CDPH SNF Antipsychotic Toolkit may reduce 
the use of antipsychotic medications compared to usual practice on the use of antipsychotic 
medication(s). The actual performance and potential gap analysis of the DNP project, including 
SWOT analysis, were identified. Gannt chart and resources and materials (see Appendix J) are 
itemized.    
Evaluation and testing in education can be challenging for nursing home staff and in 
developing a strong structured of learning and evaluation. A pre- and post-questionnaire should 
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involve planning based on the staff’s knowledge of the purpose of the learning evaluation and 
must correlate to test taker background knowledge. Pre- and post-questionnaires and workshop 
evaluation were generated to evaluate effectiveness of workshop training and the DNP project 
(see Appendix K).   
Ethical Considerations 
The University of San Francisco’s (USF, n.d.) core values are belief and commitment to 
advancing social responsibility in achieving the university’s mission to create, communicate, and 
apply knowledge to a world shared by all people. The DNP project was a quality improvement 
project approved by the USF School of Nursing and Health Professions DNP committee. The 
DNP project did not involve human subjects, and it did not require Institutional Review Board 
(IRB) for the Protection of Human Subjects approval (see Appendix L). In 1987, to protect elders 
and dependent residents from abuse and neglect in LTC facilities, federal legislation mandated 
minimum health care requirements for nursing homes, including limitations on the use of 
psychotropic medications. Any mandated reporter, within the scope of his or her employment, 
has knowledge of an incident that reasonably appears or suspects to be physical abuse, 
abandonment, abduction, isolation, financial abuse, chemical restraints, or neglect, shall report 
immediately or as soon a practicably possible (California Department of Aging, (n.d).   
The USF is committed to Jesuit values. The USF promotes a global perspective that 
educates leaders who will fashion more humane care (USF, n.d). Jesuits draw on the rich 
tradition of Ignatian spirituality and reflection and seek for the good of all humanity (Jesuits, 
n.d). This DNP project promotes Jesuits values and clinical relevance of the CDPH SNF  
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Antipsychotic Toolkit in geriatric populations. Jesuits values are well-suited with the ethical 
practice of health care using evidence-based practice. 
Results 
Qualitative Findings 
The plan was to implement the workshop training in three SNFs. Only one nursing home 
succeeded in receiving the workshop training. The three NHAs were the direct contacts for the 
DNP project.   
The first SNF is licensed with less than a 100-bed capacity in Oakland, California. The 
NHA cancelled the workshop training a week before the scheduled date. It was cancelled 
because the facility was currently experiencing widespread concern related to care that could 
potentially harm residents. The NHA stated it may take some time to correct the current problem, 
but the NHA remarked as to the importance of utilizing the SNF Antipsychotic Toolkit, since the 
use of psychotropic medications is highly regulated in the SNF. The NHA stated SNFs are 
experiencing deficiency ratings due to inappropriate use of antipsychotics and lack of 
educational training in managing residents with diagnosis of dementia.   
The second SNF is one of the largest sub-acute centers in Northern California. The 
training at this facility was cancelled on the week of the scheduled date because the Department 
of Health was there for the annual audit. The NHA corresponded that it was important to use the 
SNF Antipsychotic Toolkit to decrease the use of psychotropic medications in elderly 
populations. The NHA emphasized the importance of educating the nursing home staff with non-
pharmacological interventions and periodic workshop training in managing residents diagnosed 
with dementia.   
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The third SNF has a less than 50-bed licensed capacity. The workshop educational 
training was held as planned. The NHA has more than five years of experience in SNFs. The 
NHA specified that staff would be able to do better in understanding psychotropic regulations if 
staff utilized the CPDH SNF Antipsychotic Toolkit. The social worker at this facility has a 
Master’s in Social Work, with more than five years of experience. The social worker would like 
to learn more about the side effects of psychotropic medications. The director of utilization 
rehabilitation (DUR) therapy corresponded utilizing the CDPH SNF Antipsychotic Toolkit is 
imperative.  
The training attendees (NHA, social worker, DUR, and RN) are interested in attending a 
follow-up, more advanced workshop on this same subject. The attendees recommended that the 
workshop be offered to other colleagues. They also stated that the training was applicable to their 
job and that the educational training will more likely change their practice in relation to 
psychotropic medications.   
Quantitative Findings 
One of the three SNFs invited to participate in the training succeeded in presenting the 
educational workshop training. There were seven participants in the educational workshop 
training. Two participants were excluded in the quantitative analysis because they did not 
provide direct patient care and one nursing participant did not complete the surveys. Five 
participants were included in the analysis. See Appendix M for the full results.  
Pre-training survey. Although the staff have experience working in nursing homes, the 
findings suggest that staff need training in the use of antipsychotic medications in LTC facilities. 
Most participants felt neutral or somewhat comfortable in the use of antipsychotic medications. 
Pre training, the staff were not comfortable with answering the CMS guidelines with step-by-step 
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instructions in an effort to reduce use of unnecessary antipsychotic use. The staff were not at all 
comfortable in identifying signs and symptoms of delirium that can be mistaken as dementia in 
nursing homes. These finding suggest that the staff need training in providing non-
pharmacological interventions prior to use of psychotropic medications. Table 1 displays the full 
results from the pre-training questionnaire  
Table 1 
Pre-Training Survey 
Question Mean SD 
How comfortable are you with Department of Health Surveyors during 
annual survey in answering questions in relation of using antipsychotic 
medication with residents? 
3.60 1.14 
How comfortable are you in identifying signs and symptoms of 
delirium? 
3.80 0.84 
How comfortable are you in providing non-pharmacological 
interventions with residents manifesting behavioral disturbance 
3.80 0.84 
How comfortable are you in identifying possible adverse effects of 
antipsychotic with in older adults? 
3.60 0.55 
Post-survey. Post-training, the participants felt more comfortable, on average, with the 
use of antipsychotic medications and in identifying the signs and symptoms of delirium.  
Table 2 
Post-Training Survey  
Question Mean SD 
How comfortable are you with Department of Health Surveyors during 
annual survey in answering questions in relation of using antipsychotic 
medication with residents? 
4.60 0.55 
How comfortable are you in identifying signs and symptoms of 
delirium? 
4.60 0.55 
How comfortable are you in providing non-pharmacological 
interventions with residents manifesting behavioral disturbance 
4.60 0.55 
How comfortable are you in identifying possible adverse effects of 
antipsychotic with in older adults? 
5.00 0.00 
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Workshop evaluation. Post-training, the participants feedback on workshop training that 
it is relevant and applicable to their practice.    
Table 3 
Workshop Evaluation 
Question Mean SD 
The workshop was applicable to my job. 5.00 0.00 
I will recommend this workshop to my colleagues. 5.00 0.00 
The educational training will more likely to change my practice. 4.80 0.45 
I would be interested in attending a follow-up, more advanced 
workshop on this same subject. 
5.00 0.00 
Post-implementation. The DNP student promoted the utilization of the CDPH 
Antipsychotic Toolkit into practice. NHAs are considering enforcement in utilization of the 
CDPH Antipsychotic Toolkit into practice. The NHA and the DNP student (a former DON) are 
former colleagues in a 140-bed SNF in Northern California. The NHA and the DNP student 
utilized the CDPH Antipsychotic Toolkit in that facility, with a remarkable decrease in use of 
psychotropic medications. The NHA expressed that nursing staff, including the interdisciplinary 
team at the current facility, need to attend periodic workshop training to understand dementia, 
delirium, and the purpose of CDPH Antipsychotic Toolkit.    
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Section IV: Discussion 
Summary 
Goal 1 
Goal 1 was to implement the workshop training into at least three SNFs. The goal was 
successful with one SNF.  The DNP student contacted at least five SNFs in Bay Area, California.  
Three SNFs agreed to participate in the educational workshop training. Due to facility 
circumstances, two SNF trainings did not materialize as planned. The DNP student was able to 
implement the training at one SNF. The DNP project educational workshop training was 
implemented at a local SNF in Northern, California. The SNF is a less than 50-bed licensed 
facility located in Eastbay, California. This SNF was closed down by the DPH due to 
substandard care and negligence. It is now under new ownership and management. The SNF 
received the license to operate again in the first quarter of 2019.   
Goal 2 
Goal 2 was for the DNP student to provide educational training on delirium and 
dementia. The DNP student was able to provide introduction of clinical presentation of delirium 
in the elderly. The staff was able to identify behavioral side effects of common medications that 
could be misdiagnosed as dementia or delirium. The DNP student was able to discuss possible 
outcomes from using antipsychotic medications in elderly.  
Goal 3 
Goal 3 was to provide a behavioral modification intervention workshop training. The 
DNP student discussed possible non-pharmacological interventions in managing delirium or 
dementia with behavioral disturbance. The DNP student remarked that nursing home staff need 
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periodic training of non-pharmacological interventions in managing delirium, dementia, and 
residents with behavioral disturbance.   
Goal 4 
Goal 4 was to introduce the CDPH SNF Antipsychotic Toolkit. The DNP student was 
able to discuss the criteria and step-by-step utilization of the CDPH SNF Antipsychotic Toolkit.  
The DNP student emphasized the importance of utilization of the CDPH SNF Antipsychotic 
Toolkit to reduce the inappropriate use of psychotropic medication in current practice.   
Final Goal 
The final goal of the DNP project was to have the participating SNF utilize the CDPH 
SNF Antipsychotic Toolkit into practice. The DNP student discussed this with the NHA post-
implementation in utilizing the CDPH SNF Antipsychotic Toolkit. The NHA recommended that 
periodic workshop training is important to enforce the use of the toolkit.    
Interpretation 
Despite studies that support the danger of psychotropic drug use in older adult 
populations and an FDA black box warning about the serious side effects, psychotropic drugs are 
still commonly used in nursing homes instead of finding alternatives to managing residents’ 
behavioral and emotional states. Elder abuse and neglect is one of the complex and serious 
consequences that affects this vulnerable population (Miller, 2018). Inappropriate use of 
antipsychotic drugs is a form of elder abuse, with chemical restraints imposed for purposes of 
convenience, and is not required to treat the resident’s medical symptoms. Implementing the 
CDPH SNF Antipsychotic Toolkit will increase awareness of guidelines on the use of 
antipsychotics and in recognizing signs and symptoms of delirium with the elderly population 
residing in LTC facilities. It is critical for nursing home staff to identify signs and symptoms of 
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delirium and to communicate identified symptoms and behavior change(s) to the medical 
provider to correct modifiable risk factors of delirium (dehydration, infection, environmental risk 
factors, and medications).   
Limitations 
There were limitations identified in implementing the quality improvement project. Due 
to the educational budget, the maximum time allotted for the DNP project workshop training was 
45 minutes at the nursing home site. The learning objectives of the educational workshop 
training was for at least two hours that would include discussions. The goal of the DNP 
improvement project was to increase awareness of guidelines using antipsychotics (goal is to 
decrease use of antipsychotics) in the elderly in LTC facilities. Evaluating the effectiveness of 
DNP project in actual performance (use of antipsychotic medications) needs at least three 
quarters of the year for data collection. Use of antipsychotic medications may also depend on 
risk factors and comorbidity of residents. 
Conclusions 
Nursing home staff should have increased awareness in clinical manifestations of 
delirium (psychomotor agitation, sleep-wake reversals, irritability, anxiety, emotional lability, 
and hypersensitivity to lights and sounds), because elderly residents with delirium often do not 
look sick separately from their behavioral changes (Francis & Young, 2014). Nursing care should 
focus on minimizing negative effects of age-related changes (e.g., sensory and cognition 
impairment and chronic health conditions) and modifiable risk factors of delirium (dehydration, 
infection, environmental risk factors, medications, and restraints). The CDPH SNF Antipsychotic 
Toolkit promotes older adult wellness in physical and psychosocial function. Nursing home 
residents have the right to be free from involuntary seclusion and free from any physical or 
HAZARDS OF ANTIPSYCHOTICS IN NURSING HOMES  33 
 
chemical restraints imposed for purposes of convenience, which are not required to treat the 
resident’s medical symptoms (Braun & Frolik, 2000). Antipsychotic medications must be used 
with caution because of the serious side effects (e.g., cardiac arrest, abnormal involuntary muscle 
movement, altered liver function, and neuroleptic syndrome) that can lead to serious health 
issues. The CDPH SNF Antipsychotic Toolkit emphasizes the importance of identifying signs 
and symptoms of delirium with care for elderly in nursing homes. The CDPH SNF Antipsychotic 
Toolkit is an evidenced-based assessment toolkit that allows for ethical care of the elderly within 
the regulations and evidence-based practice for use of antipsychotics.  
Disclosure 
The DNP project was a quality improvement development approved by the DNP 
committee chair in School of Nursing and Health Professions at USF. The DNP project did not 
involve human participant subjects and did not require IRB approval. The DNP project protected 
the privacy of participants and the facility involved.   
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VI. Appendices 
HAZARDS OF ANTIPSYCHOTICS IN NURSING HOMES  40 
 
Appendix A 
CDPH L&C Antipsychotic Use Survey Toolkit 
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Appendix B 
SWOT Analysis 
Strengths 
• It provides an educational training for health care providers and nursing home 
management to learn and utilize the CDPH SNF Antipsychotic Toolkit.    
• Many nursing home staff lack training in following guidelines of antipsychotics in SNF.  
• Increase knowledge on residents’ rights in nursing homes. 
• Increase knowledge in physiological effect on antipsychotic medication in older adults.  
• Increase awareness in signs and symptoms of delirium.  
 
Weaknesses 
• NPs, MDs, Psychologist, and Psychiatrist may not attend the educational training and 
utilize CDPH SNF Antipsychotic Toolkit.   
• Nurses can use behavioral modification techniques to modify these behaviors; however, 
these interventions can be time consuming.  
Opportunities 
• Receive training on behavioral modifications of residents with a diagnosis of dementia or 
cognitive problems including behavioral symptoms.   
• The CDPH SNF Antipsychotic Toolkit can be included in the policy and procedure of the 
facility in using antipsychotics medications.   
• The nursing staff will have increased knowledge in clinical presentations of delirium in 
elderly.  
• The facility must try non-pharmacological interventions in managing behavioral 
symptom(s).  
Threats  
• It will cost money/budget to pay the nursing staff for the educational training.  
• Nursing homes are often short staffed and offer low pay, with long work hours and high 
work volume.  
• Because of the short staffing and longer work hours, caregivers do not have enough time 
to complete the policy and procedures required to document or provide safe and quality 
care, most especially maintaining dignity of residents (Weinberg, 2016).  
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Appendix C 
Gap Analysis 
Actual performance 
 
• Despite studies that support the danger of psychotropic drug use in elderly 
populations and an FDA black box warning about the serious side effects, 
psychotropic drugs are commonly used in nursing homes instead of finding 
alternatives to managing residents’ behavioral and emotional states.   
• Due to lack of training in behavioral management and knowledge in use of 
psychotropic drug therapy, nursing staff may not be aware of the dangers of these 
medications in elderly populations and may not be prepared to adequately care for 
residents with challenging behaviors (Daly et al., 2015).   
Potential 
• The utility of CDPH SNF Antipsychotic Toolkit may reduce the use of antipsychotics 
compared to usual practice in the use of antipsychotic medications.   
• Nursing staff in nursing homes, including nursing assistants, will have increased 
awareness in signs and symptoms of delirium.   
• Before prescribing a drug regimen to a resident, most especially antipsychotics, a 
comprehensive assessment and referrals to other disciplines (psychiatrist, 
psychologist, or social services) should be considered and to be aware of the possible 
adverse effects. 
• To assess and discuss possible adverse effects of the drug regimen, such as 
monitoring of lab works, abnormal involuntary body movements, and 
electrocardiogram to monitor heart rhythm.  
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Appendix D 
Health Facilities Consumer Information System 
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Appendix E 
Critical Appraisal of Evidence 
Citation Conceptual 
Framework  
Design/ 
Method 
Sample 
Setting 
Variables 
Studied and 
Their 
Definitions 
Measurement 
 
Data Analysis Findings 
Huybrechts 
et al., 2012 
 
None Quantitative 
study, 
comparative 
safety of 
antipsychotic 
medications in 
nursing home 
residents. 
Nursing homes 
in 45 U.S. 
states.   
 
83,959 Medicaid 
eligible 
residents ≥ 65 
who initiated 
antipsychotic 
treatment 
following 
nursing home 
admission in 
2001-2005. 
Reviewed data 
for an 
association 
between 
typical and 
atypical 
antipsychotics 
and the main 
side effects. 
Hospitalization 
for MI, CVA, 
bacterial 
infections & 
hip fracture 
within 180 
days of 
treatment 
initiation. 
Propensity 
score-adjusted 
proportional 
hazards models 
were used. 
 
Bacterial infections, 
myocardial infarction, and 
hip fracture rates and risks 
of cerebrovascular events 
demonstrated significant 
risk.   
Bonner et 
al., 2015 
None Qualitative 
and 
descriptive, 
rationales of 
providers and 
family 
members for 
use of 
antipsychotics 
in nursing 
home. 
26 medium and 
large facilities in 
five CMS 
regions.   
Individuals 
diagnosed 
with dementia 
who received 
an 
antipsychotic 
medication. 
 
Medical record 
abstraction, 
interviews with 
prescribers, 
staff, family.  
Coding scheme 
and coded 
reasons for 
antipsychotic 
use. 
 
Many of the prescribed 
psychotropic drugs lacked 
evidence of supporting 
documentation for 
medication necessity or 
proper diagnosis in the 
resident medical record. 
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Pakpoor & 
Agius, 
2014 
 
None Literature 
review, 
adverse side 
effects 
associated 
with 
antipsychotics 
as related to 
their efficacy. 
Review the data 
for an 
association 
between typical 
and atypical 
antipsychotics.  
 
EPS, 
metabolic 
effects, tardive 
dyskinesia – 
typical, weight 
gain, QTc.  
Not applicable. Reported 
subcategories 
side effect of 
typical, atypical 
antipsychotics.  
The study concluded 
neuroleptic malignant 
syndrome is a fatal side 
effect for all antipsychotic 
medications. 
Levin, 
2012 
None 
 
 
 
Literature 
review, lifting 
the fog: The 
problem of 
antipsychotic 
drug use in 
nursing 
facilities.   
Address 
complex 
medical issues 
of treating 
elderly in 
nursing homes 
with 
antipsychotics 
and summarize 
federal 
legislation in 
nursing homes.  
Reviewed data 
on excessive 
dependence on 
antipsychotic 
treatment for 
dementia-
related 
behavioral 
problems. 
Not applicable. Review of 
legislative, 
judicial, and 
policy 
consideration. 
Food and Drug 
Administration issued the 
black box warnings for 
antipsychotics in response 
to 15,000 nursing home 
residents dying each year 
from the off-label use of 
antipsychotic drugs. 
Azermai et 
al., 2014 
None Mixed-method 
study 
involving an 
expert 
meeting, a 
survey using 
structured 
questionnaires 
distributed to 
responsible 
nurses and 
treating 
general 
practitioners. 
On selected 
nursing home 
residents in 
Belgian nursing 
homes to 
generate case-
specific 
information. 
Antipsychotic 
users (n = 
113) had a 
mean age of 
81 years 
(range 57–97); 
62% were 
female and 
81% had 
moderate to 
severe 
cognitive 
impairment.  
 
Not stated. Not stated. Nurses and general 
practitioners share a very 
low willingness and high 
barriers to antipsychotic 
discontinuation.  
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Basso et 
al., 2018 
None Retrospective 
study using 
nursing home 
clinical 
records from 
2013-2016.  
Nursing home 
residents 
transferred to 
ED for 
respiratory, 
cardiovascular, 
and neurological 
problem and 
symptoms of 
infections. 
Not available 
 
Not stated. In 4 years (2013-
2016), 143 ED 
access occurred, 
55 (38%) for 
medical 
problems in 48 
residents.  
Most frequent reason for 
ED: infection (22) 
respiratory (18), urinary (2) 
or both (2). 
 
The week before ED 1/3 of 
residents were 
asymptomatic.  
 
ED admission prevalent 
signs: desaturation, 
dyspnea, fever. 
Kiely et al., 
2013 
None Delirium 
status was 
categorized 
into four 
groups: full, 
two or more 
symptoms, 
one symptom, 
and no 
delirium. 
 
2,158 subjects 
were recruited 
from seven 
Boston-area 
SNFs 
specialized in 
post-acute care. 
CAM – 
defined 
delirium at 
admission to 
the post-acute 
facility. 
 
Assessment 
instrument 
included Mini-
Mental Status 
Exam, 
Delirium 
Interview, 
Memorial 
Delirium 
Assessment 
Scale, and 
CAM. 
Descriptive 
statistics were 
calculated and 
chi-square 
analyses and an 
analysis-of-
variance were 
used to examine 
delirium 
characteristics 
by group. 
Among 2,158 subjects, 
16% CAM-defined 
delirium at admission to 
post-acute, 13% had two or 
more symptoms of 
delirium, 40% had one 
delirium symptom, 32% 
had no delirium symptoms. 
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Appendix F 
Gantt Chart 
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Appendix G 
Cost Benefit and Analysis 
Project Cost of In-Service in 50-Bed Facility 
Trainees 
Fair Market Rate 
Nursing Homes In 
Bay Area, California 
Per Hour 
Projected 
Staffing 
Total Cost 
Annually 
Certified Nursing Assistant  
(CNA)  
$18.00 x 1.5 hours 22 CNAs $594.00 
Licensed Vocational Nurse 
(LVN)  
$30.00 x 1.5 hours 12 LVNs $540.00 
Registered Nurse (RN) $45.00 x 1.5 hours 6 RNs $405.00 
Social Worker (SW) $35.00 x 1.5 hours 1 SW $52.50 
PROJECTED TOTAL COST $1,591.50 
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Appendix H 
Flyer 
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Appendix I 
Work Breakdown System / Communication Plan 
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Appendix J 
Resources and Materials 
Print Materials 
• California Department of Health L&C SNF Antipsychotic Use Survey Toolkit 
• Power Point presentation on Hazards of Antipsychotics in Nursing Homes 
• Pre- and post-questionnaires 
• Workshop Evaluation 
• Agenda 
• Flyers 
Online Access Resources 
• California Department of Health L&C SNF Antipsychotic Use Survey Toolkit: 
https://www.caltcm.org/assets/documents/forms/cdph_lc_antipsychotic_survey_tool_
07_11_12.pdf 
• Department of Health & Human Services. Centers for Medicare & Medicaid 
Services. CMS Manual System: https://www.cms.gov/Regulations-and-
Guidance/Guidance/Transmittals/downloads/R22SOMA.pdf 
• Long-Term Care Community Coalition: 
http://www.ltccc.org/publications/documents/ltccc-antipsychotic-drugs-oversight-
ftags-mar2013.pdf  
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Appendix K 
Pre- and Post-Questionnaire and Workshop Evaluation 
Pre-Questionnaire 
 
Your response will provide the best possible outcome of the educational training. 
 
What is your job title? 
 MD     NP     RN    LVN    Others_____ 
 
How many years of experience in your profession? 
 <1 year    2-3 years     4-5 years    > 5 years   
 
Did you ever use or know about the SNF Antipsychotic Toolkit prior to this training? 
 YES     NO  
 
1. How comfortable are you in identifying or recognizing signs and symptoms of delirium?  
 
                                                        
Least Comfortable            1           2           3           4           5            Very Comfortable 
 
2. How comfortable are you what to examine to a resident before administering or prescribing 
antipsychotic medication in nursing skilled facility within the regulation?  
 
                                                        
Highly Comfortable          1           2           3           4           5            Very Comfortable 
 
3. How comfortable are you in providing non-pharmacological interventions with resident manifesting 
behavioral disturbance?  
 
                                                        
Highly Comfortable          1           2           3           4           5            Very Comfortable 
 
4. How comfortable are you with Department of Health Surveyors during annual survey in answering 
questions in relation of using antipsychotic medication with residents?  
 
                                                        
Highly Comfortable           1           2           3           4           5            Very Comfortable 
 
5. How comfortable are you in identifying possible adverse effects of antipsychotic medication with in 
older adults?  
                                                       
Highly Comfortable         1           2           3           4           5            Very Comfortable 
 
6. How comfortable are you when verifying or prescribing antipsychotic medication in nursing skilled 
facility within the regulation?  
 
                                                        
Least Comfortable            1           2           3           4           5            Very Comfortable 
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Post-Questionnaire 
Your response will provide the best possible outcome of the educational training. 
 
 
1. How comfortable are you in identifying signs and symptoms of delirium?  
 
                                                        
Least Comfortable            1           2           3           4           5            Very Comfortable 
 
2. How comfortable are you what to rule out before administering or prescribing antipsychotic 
medication in nursing skilled facility within the regulation?  
 
                                                        
Least Comfortable            1           2           3           4           5            Very Comfortable 
 
3. How comfortable are you in providing non-pharmacological interventions with resident manifesting 
behavioral disturbance?  
 
                                                        
Least Comfortable            1           2           3           4           5            Very Comfortable 
 
4. How comfortable are you with Department of Health Surveyors during annual survey in answering 
questions in relation of using antipsychotic medication with residents?  
 
                                                        
Least Comfortable            1           2           3           4           5            Very Comfortable 
 
5. How comfortable are you in identifying possible adverse effects of antipsychotic medication with in 
older adults?  
                                                       
Least Comfortable            1           2           3           4           5            Very Comfortable 
 
 
6. How comfortable are you when verifying or prescribing antipsychotic medication in nursing skilled 
facility within the regulation?  
 
                                                        
Least Comfortable            1           2           3           4           5            Very Comfortable 
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Workshop Evaluation Form 
Training Location: __________________________________ 
 
Date: _______________________ 
 
Job Title: ____________________ 
 
Years in present position?  <1       1-3        3-5       +5 
 
INSTRUCTIONS: 
Please  
   Strongly    Strongly 
   agree    disagree  
1. I was well informed about the objectives of this workshop  1 2 3 4 5      
 
2. The workshop was applicable to my job 1 2 3 4 5    
 
3. I will recommend this workshop to my colleagues 1 2 3 4 5      
  
4. The program was well paced within the allotted time 1 2 3 4 5      
 
5. The educational training will more likely change my practice 1 2 3 4 5      
 
6. The material was presented in an organized manner 1 2 3 4 5      
 
7. The instructor was knowledgeable on the topic 1 2 3 4 5      
 
8. I would be interested in attending a follow-up, more  
          advanced workshop on this same subject 1 2 3 4 5     
 
9. I would be interested in attending a follow-up, more  
          advanced workshop on this same subject 1 2 3 4 5     
 
10. Given the topic, was this workshop:       ❑ a. Too short     ❑ b. Right length    ❑ c. Too long  
 
11. In your opinion, was this workshop:       ❑ a. Introductory ❑ b. Intermediate   ❑ c. Advanced 
 
12. What did you most appreciate/enjoy/think was best about the course? Any suggestions for 
improvement? 
 
 
 
 
14. What is the least valuable about this workshop? 
 
 
15. What is the most valuable about this workshop? 
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16. I would be able to do my work better if I knew more about> 
 
 
 
 
17. Please describe the top two topics you would like to learn more about in the next 12 months: 
 
 
 Topic  
 
1:_____________________________________________________________________________ 
 
 
 
 Topic  
 
2:_____________________________________________________________________________ 
 
  
   
 
 
 
 
 
 
Please return this form to the instructor or organizer at the end of the workshop.  Thank you. 
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Appendix L 
DNP Statement of Non-Research Determination Form 
Student Name:  Nino D. Flores, RN MSN  
Title of Project: Hazards of Antipsychotic in Nursing Homes 
Brief Description of Project: Introduction of the California Department of Public 
Health’s Skilled Nursing Facility (CDPH SNF) Antipsychotic Toolkit may reduce the use 
and or prescribing of antipsychotic medications compared to usual practice of 
antipsychotic use.  Delirium and altered in mental status are associated with multiple 
complex underlying medical conditions and they can be difficult to recognize, 
particularly among elderly residing in long term care facilities.   
A) Aim Statement: The use of the CDPH SNF Antipsychotic Toolkit allows for 
ethical and evidence-based care of the elderly within the regulations and best practice 
for use of antipsychotics.   
B) Description of Intervention: Quality improvement project is to provide: a) an 
educational training on delirium and dementia, b) behavioral modifications, and c) 
introducing CDPH SNF Antipsychotic Toolkit to local nursing homes in Northern, 
California.   
C) How will this intervention change practice? Increase awareness and knowledge 
in regulations use of CDPH SNF Antipsychotic Toolkit may decrease use of 
antipsychotics in residents of nursing homes and to increase awareness signs and 
symptoms of delirium.   
D) Outcome measurements: Pre and Post survey questionnaires, and workshop 
evaluation will be administered to healthcare participants.   
 
To qualify as an Evidence-based Change in Practice Project, rather than a Research Project, the 
criteria outlined in federal guidelines will be used:  
(http://answers.hhs.gov/ohrp/categories/1569)  
☐ x   This project meets the guidelines for an Evidence-based Change in Practice Project as 
outlined in the Project Checklist (attached). Student may proceed with implementation. 
☐This project involves research with human subjects and must be submitted for IRB approval 
before project activity can commence
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Comments:   
EVIDENCE-BASED CHANGE OF PRACTICE PROJECT CHECKLIST * 
 
Instructions: Answer YES or NO to each of the following statements: 
Project Title: Hazards of Antipsychotics in Nursing Home  
 
YES NO 
The aim of the project is to improve the process or delivery of care with 
established/ accepted standards, or to implement evidence-based change. There is 
no intention of using the data for research purposes. 
Yes  
The specific aim is to improve performance on a specific service or program and is 
a part of usual care.  ALL participants will receive standard of care. 
Yes  
The project is NOT designed to follow a research design, e.g., hypothesis testing 
or group comparison, randomization, control groups, prospective comparison 
groups, cross-sectional, case control). The project does NOT follow a protocol that 
overrides clinical decision-making. 
Yes  
The project involves implementation of established and tested quality standards 
and/or systematic monitoring, assessment or evaluation of the organization to 
ensure that existing quality standards are being met. The project does NOT 
develop paradigms or untested methods or new untested standards. 
Yes  
The project involves implementation of care practices and interventions that are 
consensus-based or evidence-based. The project does NOT seek to test an 
intervention that is beyond current science and experience. 
Yes  
The project is conducted by staff where the project will take place and involves 
staff who are working at an agency that has an agreement with USF SONHP. 
Yes  
The project has NO funding from federal agencies or research-focused 
organizations and is not receiving funding for implementation research. 
Yes  
The agency or clinical practice unit agrees that this is a project that will be 
implemented to improve the process or delivery of care, i.e., not a personal 
research project that is dependent upon the voluntary participation of colleagues, 
students and/ or patients. 
Yes  
If there is an intent to, or possibility of publishing your work, you and supervising 
faculty and the agency oversight committee are comfortable with the following 
statement in your methods section:  “This project was undertaken as an Evidence-
based change of practice project at X hospital or agency and as such was not 
formally supervised by the Institutional Review Board.”  
Yes  
 
ANSWER KEY: If the answer to ALL of these items is yes, the project can be considered an 
Evidence-based activity that does NOT meet the definition of research.  IRB review is not 
required.  Keep a copy of this checklist in your files.  If the answer to ANY of these questions 
is NO, you must submit for IRB approval. 
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*Adapted with permission of Elizabeth L. Hohmann, MD, Director and Chair, Partners Human 
Research Committee, Partners Health System, Boston, MA.   
 
 
 
 
STUDENT NAME (Please print):  
 
Nino Dantes Flores, RN MSN 
________________________________________________________________________ 
 
Signature of Student: 
______________________________________________________DATE____________         
 
SUPERVISING FACULTY MEMBER (CHAIR) NAME (Please print):   
 
Dr. Jo Loomis, DNP, FNP-C, CHSE, CLC, ANLC, NCMP, CNL 
________________________________________________________________________ 
 
Signature of Supervising Faculty Member (Chair): 
______________________________________________________DATE____________ 
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Appendix M 
Results 
 
 
 
